← Back to Dashboard

Lovastatin

HMG-CoA reductase inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C
PCZOHLXUXFIOCF-BXMDZJJMSA-N

Clinical Development by Virus7

Dengue virus
DENV-2
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human orthopneumovirus
RSV
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus B
CVB-3
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zaire ebolavirus
EBOV
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human respirovirus 1
HPIV-1
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rotavirus A
RoV-SA11
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Human HMGCR
Preclinical
Preclinical
Phase 2
Phase 3
Approved